Laurus Labs is currently trading at Rs. 893.15, up by 55.10 points or 6.57% from its previous closing of Rs. 838.05 on the BSE. The scrip opened at Rs. 834.00 and has touched a high and low of Rs. 901.00 and Rs. 827.95 respectively. So far 786220 shares were traded on the counter. The BSE … Read more
Laurus Labs is currently trading at Rs. 493.25, up by 7.80 points or 1.61% from its previous closing of Rs. 485.45 on the BSE. The scrip opened at Rs. 483.90 and has touched a high and low of Rs. 493.90 and Rs. 478.40 respectively. So far 73603 shares were traded on the counter. The BSE … Read more
Laurus Labs has signed an investment agreement with Immunoadoptive Cell Therapy (ImmunoACT), an advanced cell and gene therapy company to acquire 26.62% stake (fully diluted basis), subject to completion of conditions precedent, for a cash consideration of approximately Rs 46.00 crore. Additionally, senior management of Laurus Labs would also invest in ImmunoACT for a 5.64% … Read more
